Physician profile
Javed Malik
NPI 1457666497
$3,616.33
in general payments reported to CMS, 2019-2025
43 companies · $944 in 2025
The $944 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $16.23 · 2021: $407 · 2022: $287 · 2023: $484 · 2024: $1,203 · 2025: $944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,331 · Long Term Medical Supply Or Device Loan: $1,280 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,330.88 |
| Long Term Medical Supply Or Device Loan | $1,279.73 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,532.60 | 2022-2025 | |
| Genentech USA, INC. | $220.37 | 2019-2025 | Venclexta, Itovebi, Tecentriq |
| Astrazeneca Pharmaceuticals LP | $160.60 | 2019-2025 | Lynparza, Imfinzi |
| E.R. Squibb & Sons, L.L.C. | $158.46 | 2019-2025 | Opdivo |
| Amgen INC. | $131.07 | 2019-2022 | |
| Abiomed | $118.52 | 2025 | |
| Merck Sharp & Dohme LLC | $105.13 | 2019-2024 | Keytruda |
| Celgene Corporation | $102.25 | 2021-2024 | Pomalyst |
| Janssen Biotech, INC. | $97.46 | 2021-2025 | Tecvayli, Talvey |
| Daiichi Sankyo INC. | $66.68 | 2023-2024 | Enhertu |
| Incyte Corporation | $66.28 | 2022-2025 | Monjuvi, Jakafi |
| Pfizer INC. | $63.84 | 2019-2024 | |
| Genzyme Corporation | $61.64 | 2019-2022 | |
| Pharmacyclics LLC, An Abbvie Company | $56.29 | 2023 | Imbruvica, Epkinly |
| Emd Serono, INC. | $44.37 | 2023 | Bavencio |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javed Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.